Genome-based vaccine development: A short cut for the future

Advances in Experimental Medicine and Biology

Volumn 655, Issue , 2009, Pages 81-89

  Moriel, Danilo Gomes ^b   Scarselli, Maria ^b   Serino, Laura ^b   Mora, Marirosa ^b   Rappuoli, Rino ^a   Masignani, Vega ^b  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; HAEMOPHILUS VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; ANTIGEN; BACTERIAL ANTIGEN;

ARTICLE; BACTERIAL GENOME; BACTERIAL INFECTION; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; EPIDEMIC MENINGITIS; GENE SEQUENCE; GENETIC IMMUNIZATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MENINGOCOCCEMIA; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VACCINE PRODUCTION; BIOLOGICAL MODEL; CHEMISTRY; DRUG DESIGN; GENETICS; GENOME; METABOLISM; NEISSERIA MENINGITIDIS; REVIEW; STREPTOCOCCUS AGALACTIAE;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS; STREPTOCOCCUS AGALACTIAE;

ANTIGENS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; DRUG DESIGN; GENETIC VARIATION; GENOME; GENOME, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; NEISSERIA MENINGITIDIS; STREPTOCOCCUS AGALACTIAE;

EID: 77955493994     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1132-2_8     Document Type: Article

References (22)

1. Fraser CM, Rappuoli R. Application of microbial genomic science to advanced therapeutics, Annu Rev Med 2005; 56:459-474. (Pubitemid 40299793)
2. FDA. Vaccines licensed for immunization and distribution in the USA. http://www.fda.gov/cbet/vaccine/licvacc .htm. Accessed in 08/13/2007.
3. André FE. Vaccinology: past achievements, present roadblocks and future promises. Vaccine 2003, 21:593-595. (Pubitemid 36091965)
4. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007,6:404-414. (Pubitemid 46696551)
5. Rappuoli R. Reverse Vaccinology. Curr Opin Microbiol 2000, 3:445-450.
6. Plotkin SA. Vaccines: past, present and future. Nat Med 2005, 11(4 Suppl):S5-S11. (Pubitemid 40562297)
7. Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
8. Mora M, Veggi D, Santini L et al. Reverse vaccinology. Drug Discov Today 2003,8(10):459-464. (Pubitemid 36683276)
9. Tettelin H, Masignani V, Cieslewicz MJ et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiac. Proc Natl Acad Sci USA 2002 ; 99:12391-12396.
10. Maione D, Margarit I, Rinaudo CD et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005; 309:148-150. (Pubitemid 40934997)
11. Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001; 69:1593-1598. (Pubitemid 32187614)
12. Ariel N, Zvi A, Grosfeld H et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXOl: in silico and in vitro screening. Infect Immun 2002, 70:6817-6827. (Pubitemid 35387914)
13. Montigiani S, Falugi F, Scarselli M et al. Genomic approach for analysisof surface proteins in Chlamydia pneumoniae. Infect Immun 2002, 70:368-379. (Pubitemid 34028637)
14. Ross BC, Czajkowski L, Hocking D et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 2001; 19: 4135-4142. (Pubitemid 32703633)
15. Tettelin H, Medini D, Donati C et al. Towards a universal group B Streptococcus vaccine using multistrain genome analysis. Expert Rev Vaccines 2006; 5(5):687-694. (Pubitemid 46021049)
16. Medini D. Donati C. Tettelin H et al. The microbial pan-genome. Curr Opin Genet Dev 2005 ; 15:589-594. (Pubitemid 41532330)
17. Mora M. Donati C. Medini D et al. Microbial genomes and vaccine design: refinements to the classical riverse vaccinology approach. Curr Opin in Microbiol 2006; 9:532-536. (Pubitemid 44397631)
18. Alekshun MN. Levy SB. Commensal upon us. Biochern Pharmacol 2006; 71:893-900.
19. O'Hara AM. Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7(7):688-693. (Pubitemid 43986264)
20. Dagan R. The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otoryngology: the case of acute otitis media. Curr Opin Otoryngol Head Neck Surg 2004; 12(6):488-494. (Pubitemid 39565202)
21. Satola SW; Schirmer PL. Farley MM. Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infect Immun 2003; 71(12) :7202-7207. (Pubitemid 37475358)
22. NCBI Microbial Genornes. http://www.ncbi.nlm.nih.gov/genomes/MICROBES/ microbial-taxtree.html. Accessed in 08/13/2007.